The loss, which compared with an under $1 million loss in the same period last year, was mainly down to higher operating losses and higher interest expenses. Cano Health’s operating loss for the first quarter totaled $39.5 million compared with an $11.5 million loss in the same period in 2022.
Cano Health, which has been the subject of recent controversy after three former directors resigned from the board and urged the removal of CEO Marlow Hernandez, DO, is pursuing the sale of certain non-core assets and has retained Oppenheimer & Co. as a financial adviser.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
